Financials FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
21.42 USD +0.09% Intraday chart for FUSN PHAR +0.75% +122.89%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 490.3 179.6 141 695.8 1,820 - -
Enterprise Value (EV) 1 267.9 -21.21 -29.87 462.2 1,718 1,649 1,771
P/E ratio -3.25 x -2.19 x -1.58 x -6.63 x -14.4 x -13 x -12.1 x
Yield - - - - - - -
Capitalization / Revenue - 125 x 96.5 x 336 x 2,371 x 3,501 x 301 x
EV / Revenue - -14.7 x -20.4 x 224 x 2,239 x 3,172 x 293 x
EV / EBITDA -7.15 x 0.26 x 0.34 x -4.72 x -13.6 x -11.1 x -12.8 x
EV / FCF - 0.27 x 0.4 x -5.39 x -17.1 x -13.6 x -12.6 x
FCF Yield - 364% 252% -18.5% -5.86% -7.33% -7.94%
Price to Book 8.79 x 0.78 x 0.85 x 3.44 x 43.7 x 25.2 x 306 x
Nbr of stocks (in thousands) 41,726 43,066 44,763 72,406 84,966 - -
Reference price 2 11.75 4.170 3.150 9.610 21.42 21.42 21.42
Announcement Date 3/25/21 3/17/22 3/16/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - 1.44 1.461 2.068 0.7676 0.5199 6.042
EBITDA 1 - -37.45 -81.38 -87.12 -97.89 -126.5 -149.1 -138.4
EBIT 1 -18.22 -37.94 -82.02 -88.03 -99.23 -122.6 -143.3 -164
Operating Margin - - -5,695.49% -6,025.6% -4,798.45% -15,971.48% -27,565.23% -2,714.67%
Earnings before Tax (EBT) 1 - -75.72 -81.16 -89.45 -94.11 -118.4 -141.2 -164
Net income 1 - -78.33 -81.05 -87.61 -94.9 -116.5 -140.8 -164
Net margin - - -5,628.26% -5,996.71% -4,588.83% -15,175.7% -27,080.77% -2,713.79%
EPS 2 -0.1600 -3.620 -1.900 -2.000 -1.450 -1.489 -1.652 -1.774
Free Cash Flow 1 - - -77.23 -75.42 -85.69 -100.7 -120.9 -140.6
FCF margin - - -5,363.26% -5,162.08% -4,143.71% -13,117.87% -23,246.07% -2,327.48%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/3/20 3/25/21 3/17/22 3/16/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 0.325 0.594 0.585 0.57 0.166 0.14 0.028 0.034 2.006 - 0.1264 0.1445 0.3895 0.1451 -
EBITDA - - - - - - - - -19.02 - - - - - -
EBIT 1 -19.52 -17.55 -20.52 -19.29 -23.8 -24.42 -24.86 -26.71 -19.39 -28.28 -28.93 -30.5 -31.07 -31.93 -35
Operating Margin -6,004.62% -2,955.05% -3,508.55% -3,383.68% -14,340.36% -17,440.71% -88,767.86% -78,567.65% -966.55% - -22,893.81% -21,109.9% -7,977.82% -22,003.86% -
Earnings before Tax (EBT) 1 -19.38 -17.41 -19.96 -19.75 -24.77 -24.96 -24.3 -25.42 -17.5 -26.88 -27.29 -28.82 -28.47 -29.72 -35
Net income 1 -19.43 -17.24 -19.91 -19.07 -24.01 -24.62 -24.29 -25.18 -17.25 -28.18 -27.84 -29.21 -29.21 -30.5 -35
Net margin -5,978.15% -2,901.68% -3,403.25% -3,346.14% -14,465.66% -17,583.57% -86,753.57% -74,044.12% -860.02% - -22,028.11% -20,212.63% -7,500.29% -21,014.68% -
EPS 2 -0.4500 -0.4000 -0.4600 -0.4400 -0.5500 -0.5500 -0.4500 -0.3800 -0.2500 -0.3900 -0.3678 -0.3711 -0.3678 -0.3778 -0.3950
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/9/21 3/17/22 5/10/22 8/9/22 11/8/22 3/16/23 5/11/23 8/8/23 11/7/23 3/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 222 201 171 234 102 171 49.1
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -77.2 -75.4 -85.7 -101 -121 -141
ROE (net income / shareholders' equity) -60% -30.8% -44.5% -49.3% -105% -145% -188%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 1.340 5.370 3.710 2.790 0.4900 0.8500 0.0700
Cash Flow per Share - - - - - - -
Capex 1 1.12 1.49 2.14 3.89 1.82 2.12 2.47
Capex / Sales - 103.54% 146.61% 188.1% 236.83% 407.39% 40.85%
Announcement Date 3/25/21 3/17/22 3/16/23 3/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
21.42 USD
Average target price
21.55 USD
Spread / Average Target
+0.61%
Consensus